MCM
BSX icon

Mill Capital Management’s Boston Scientific BSX Stock Holding History

Mill Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.85M Buy
230,815
+81,059
+54% +$4.4M 0.66% 34
2026
Q1 		$9.4M Buy
149,756
+42,453
+40% +$3.4M 0.71% 33
2025
Q4 		$10.2M Buy
+107,303
New +$10.5M 0.74% 33

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mill Capital Management's BSX Position: Q2 2026 in Review

Mill Capital Management increased its Boston Scientific (BSX) stake by 54% in Q2 2026, buying an estimated $4.4M and bringing the position to 230,815 shares worth $9.85M. The position accounts for 0.66% of the portfolio, ranked #34.

Mill Capital Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.2M in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mill Capital Management held 230,815 shares of Boston Scientific worth $9.85M as of Q2 2026.
  • Mill Capital Management bought 81,059 Boston Scientific shares in Q2 2026, an estimated $4.4M.
  • Boston Scientific made up 0.66% of Mill Capital Management's portfolio in Q2 2026, its #34 holding.
  • Mill Capital Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Mill Capital Management's Boston Scientific position peaked at $10.2M in Q4 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mill Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.